Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yoh ichiro Iwasa"'
Autor:
Yoh-ichiro Iwasa, Moeka Shimizu, Kazuki Matsuura, Kentaro Hori, Ken Hiramatsu, Kenjiro Sugiyama, Yoh Yokota, Tomohiro Kitano, Ryosuke Kitoh, Yutaka Takumi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract This study aimed to investigate the prognostic value of hematological biomarkers measured before and after treatment in patients with head and neck cancer (HNC). This study reviewed 124 patients with HNC who received chemoradiotherapy. Hemat
Externí odkaz:
https://doaj.org/article/2782415b05cd4cb7a9a79825af78f15d
Autor:
Yoh-ichiro Iwasa, Tomoyuki Nakajima, Kentaro Hori, Yoh Yokota, Ryosuke Kitoh, Takeshi Uehara, Yutaka Takumi
Publikováno v:
Biomolecules, Vol 13, Iss 12, p 1685 (2023)
Although anti-programmed death-1 (PD-1) antibody therapy improves the prognosis in patients with head and neck squamous cell carcinoma (HNSCC), some patients exhibit disease progression even after showing a good response to the treatment initially be
Externí odkaz:
https://doaj.org/article/e60c9b81d9fe4dc89f92168be18dd35c
Autor:
YOH-ICHIRO IWASA, RYOSUKE KITOH, YOH YOKOTA, KENTARO HORI, MARIKO KASUGA, TAKASHI KOBAYASHI, SHINTARO KANDA, YUTAKA TAKUMI
Publikováno v:
Cancer Diagnosis & Prognosis; Mar/Apr2024, Vol. 4 Issue 2, p182-188, 7p
Autor:
Yoh-Ichiro Iwasa, Shin-Ya Nishio, Akiko Sugaya, Yuko Kataoka, Yukihiko Kanda, Mirei Taniguchi, Kyoko Nagai, Yasushi Naito, Tetsuo Ikezono, Rie Horie, Yuika Sakurai, Rina Matsuoka, Hidehiko Takeda, Satoko Abe, Chiharu Kihara, Takashi Ishino, Shin-Ya Morita, Satoshi Iwasaki, Masahiro Takahashi, Tsukasa Ito, Yasuhiro Arai, Shin-Ichi Usami
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0215932 (2019)
The OTOF gene (Locus: DFNB9), encoding otoferlin, is reported to be one of the major causes of non-syndromic recessive sensorineural hearing loss, and is also reported to be the most common cause of non-syndromic recessive auditory neuropathy spectru
Externí odkaz:
https://doaj.org/article/5b4d97771f374fe9b4900e835e3a8700
Autor:
Yoh-ichiro Iwasa, Yoh Yokota, Ryosuke Kitoh, Kentaro Mori, Keita Tsukada, Nodoka Sekiguchi, Toshirou Fukushima, Takashi Kobayashi, Shintaro Kanda, Yutaka Takumi, Tomonobu Koizumi
Publikováno v:
Oncology. 100:203-211
Background: Nivolumab, a programmed death-1 antibody, is an immune checkpoint inhibitor approved in Japan in March 2017 for the treatment of recurrent or metastatic head and neck cancers (RM-HNCs) after platinum drug administration. This study aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42791089ca617386dfa3024cecaf3bb
https://doi.org/10.1159/000522035
https://doi.org/10.1159/000522035
Publikováno v:
International Journal of Practical Otolaryngology. :e29-e38
Concurrent chemoradiotherapy (CCRT) is one of the standard treatment strategies for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Prophylactic percutaneous gastrostomy (pPEG) has been reported to be useful for nutritio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::370c46f5df7eda45f1dfe9cc7021820e
https://doi.org/10.1055/s-0042-1758860
https://doi.org/10.1055/s-0042-1758860
Publikováno v:
Chemotherapy.
Treatment of synchronous multiple primary cancers is clinically difficult. We report four cases of synchronous primary cancers, including advanced and metastatic non-small cell lung cancer (NSCLCs) highly positive for programmed death-ligand 1 (PD-L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::223a061d626204e7add66eb611de41ee
https://doi.org/10.1159/000528592
https://doi.org/10.1159/000528592
Autor:
Yoh-Ichiro Iwasa, Keita Tsukada, Masafumi Kobayashi, Tomohiro Kitano, Kentaro Mori, Hidekane Yoshimura, Hisakuni Fukuoka, Shin-Ichi Usami
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0206891 (2018)
The purpose of this study was to assess the diagnostic performance of 3T MRI after intratympanic injection of gadodiamide for delayed endolymphatic hydrops (DEH), and assess the relationship between endolymphatic hydrops (ELH) and vestibular function
Externí odkaz:
https://doaj.org/article/9580b30703f343a8a4205f533fdcbcac
Autor:
Takashi Ishino, Daisuke Kikuchi, Toshinori Kubota, Noriko Ogasawara, Misako Hyogo, Chiharu Kihara, Tomoko Esaki, Satoshi Iwasaki, Jun Nakayama, Masahiro Takahashi, Yumiko Kobayashi, Yoh ichiro Iwasa, Masako Nakai, Yuika Sakurai, Mayuri Okami, Hidehiko Takeda, Sakiko Furutate, Nana Tsuchihashi, Yukihide Maeda, Marina Kobayashi, Hiroshi Yoshihashi, Tomoko Shintani, Tadao Yoshida, Tetsuo Ikezono, Hidekane Yoishimura, Shin-ichi Usami, Han Matsuda, Yasuhiro Arai, Yuko Kataoka, Kozo Kumakawa, Taisuke Kobayashi, Risa Tona, Kyoko Nagai, Shinya Morita, Akiko Sugaya, Yohei Honkura, Remi Motegi, Shuji Izumi, Hiroshi Yamazaki, Yasushi Naito, Shin-ya Nishio, Yuzuru Ninoyu, Hideaki Sakata, Yukihiko Kanda, Shinichiro Oka, Mayumi Suematsu
Publikováno v:
Human Genetics. 141:865-875
Mutations in the OTOF gene are a common cause of hereditary hearing loss and the main cause of auditory neuropathy spectrum disorder (ANSD). Although it is reported that most of the patients with OTOF mutations have stable, congenital or prelingual o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a301f97d03cfb9bfd9bb56a8135cd1a3
https://doi.org/10.1007/s00439-021-02351-7
https://doi.org/10.1007/s00439-021-02351-7
Autor:
Yoh-Ichiro Iwasa, Ryosuke Kitoh, Ken Hiramatsu, Kenjiro Sugiyama, Kizuki Watanabe, Rika Yasukawa, Jun Shinagawa, Hiroki Miyajima, Yoh Yokota, Masafumi Kobayashi, Tomohiro Kitano, Kentaro Mori, Yutaka Takumi
Publikováno v:
ORL; journal for oto-rhino-laryngology and its related specialties.
Introduction: Sarcopenia, characterized by low skeletal muscle mass, and the outcome of cancer therapy are closely related based on recent research. This study aimed to evaluate the correlation between skeletal muscle mass and prognosis in head and n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad0485c3aa8f313ed2fa60a5fcc8deb
https://pubmed.ncbi.nlm.nih.gov/36423591
https://pubmed.ncbi.nlm.nih.gov/36423591